Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications (Q34061211)

30 July 2017

1 reference

title

Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications (English)

1 reference

30 July 2017

0 references

S A Cohen

1

1 reference

PubMed ID

11033455

30 July 2017

M Trikha

series ordinal

2

1 reference

PubMed ID

11033455

30 July 2017

M A Mascelli

series ordinal

3

1 reference

30 July 2017

1 January 2000

1 reference

Pathology Oncology Research

30 July 2017

1 reference

30 July 2017

6

1 reference

30 July 2017

3

1 reference

30 July 2017

163-174

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03032368

30 July 2017

0 references

cites work

The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

Survival and recurrence following stroke. The Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

Lifetime cost of stroke in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

Incidence rates of stroke in the eighties: the end of the decline in stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03032368

Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival

21 January 2018

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Human prostate carcinoma cells express functional alphaIIb(beta)3 integrin

1 reference

12 December 2020

Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries

1 reference

12 December 2020

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

12 December 2020

Epidemiologic profile of long-term stroke disability: the Framingham study

1 reference

12 December 2020

Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells.

1 reference

12 December 2020

Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow

1 reference

12 December 2020

In vitro release of vascular endothelial growth factor during platelet aggregation.

1 reference

12 December 2020

Involvement of platelets in tumour angiogenesis?

1 reference

12 December 2020

Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb.

1 reference

12 December 2020

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

12 December 2020

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

1 reference

12 December 2020

Beta3 integrin expression in melanoma predicts subsequent metastasis

1 reference

12 December 2020

Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Compl

1 reference

12 December 2020

New developments in angiogenesis: a major mechanism for tumor growth and target for therapy.

1 reference

12 December 2020

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

12 December 2020

Sickle reticulocytes adhere to VCAM-1.

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins

1 reference

12 December 2020

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

12 December 2020

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

1 reference

12 December 2020

The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease

1 reference

12 December 2020

Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation

1 reference

12 December 2020

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity

1 reference

12 December 2020

Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death

1 reference

12 December 2020

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators

1 reference

12 December 2020

Circulating activated endothelial cells in sickle cell anemia

1 reference

12 December 2020

Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells

1 reference

12 December 2020

Inhibition of metastases by anticoagulants

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Platelet activation during pain crisis in sickle cell anemia patients

1 reference

12 December 2020

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets

1 reference

12 December 2020

Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.

1 reference

12 December 2020

The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension

1 reference

12 December 2020

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

12 December 2020

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

1 reference

12 December 2020

Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells

1 reference

12 December 2020

Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition

1 reference

12 December 2020

The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cells

1 reference

12 December 2020

A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1)

1 reference

12 December 2020

The rational clinical examination. Clinical assessment of stroke

1 reference

12 December 2020

Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease.

1 reference

12 December 2020

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

12 December 2020

Chromosomal localization of human β globin gene on human chromosome 11 in somatic cell hybrids

1 reference

12 December 2020

Immunoreactivity of glycoprotein IIb is present in metastasized but not in non-metastasized primary malignant melanoma.

1 reference

12 December 2020

Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma

1 reference

12 December 2020

A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy

1 reference

12 December 2020

Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells

1 reference

12 December 2020

Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors

1 reference

12 December 2020

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

12 December 2020

Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents

1 reference

12 December 2020

The pathophysiology of vascular obstruction in the sickle syndromes

1 reference

12 December 2020

Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel

1 reference

12 December 2020

Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation

1 reference

12 December 2020

The natural history of sickle cell disease

1 reference

12 December 2020

Randomized, Placebo-Controlled Study of Lamifiban with Thrombolytic Therapy for the Treatment of Acute Myocardial Infarction: Rationale and Design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial

1 reference

12 December 2020

Newborn screening for sickle cell disease: effect on mortality

1 reference

12 December 2020

Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer

1 reference

12 December 2020

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

12 December 2020

Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia

1 reference

12 December 2020

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

1 reference

12 December 2020

Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.

1 reference

12 December 2020

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group

1 reference

12 December 2020

Genetics of red cells and susceptibility to malaria

1 reference

12 December 2020

Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo

1 reference

12 December 2020

Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis

1 reference

12 December 2020

Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin

1 reference

12 December 2020

Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

12 December 2020

Thrombolytic therapy with streptokinase in acute ischemic stroke.

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study

1 reference

12 December 2020

Platelet-activating factor in plasma of patients with sickle cell disease in steady state

1 reference

12 December 2020

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

1 reference

12 December 2020

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

1 reference

12 December 2020

Molecular determinants of angiogenesis in cancer metastasis.

1 reference

12 December 2020

Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects

1 reference

12 December 2020

Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion

1 reference

12 December 2020

Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa

1 reference

12 December 2020

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

1 reference

12 December 2020

Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.

1 reference

12 December 2020

Kinetics, distribution and sites of destruction of 111indium-labelled human platelets

1 reference

12 December 2020

Laboratory markers of platelet activation and their clinical significance

1 reference

12 December 2020

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group

1 reference

12 December 2020

Platelet-erythrocyte adhesion in sickle cell disease

1 reference

12 December 2020

Inhibition of angiogenesis and tumor growth by murine 7E3, the parent antibody of c7E3 Fab (abciximab; ReoPro)

1 reference

12 December 2020

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03032368

1 reference

30 July 2017

1 reference

PubMed ID

11033455